US export certificates guidance updates:
This article was originally published in Clinica
The US FDA has updated its 2002 guidance document on export certificates, which are often demanded by foreign governments to demonstrate that the product being exported can be marketed in the US or meets specific US regulations. The agency has the option of charging a fee of up to $175 if it issues a certificate within 20 government working days of receipt of a complete request for such a document.
You may also be interested in...
Final data comparing cabotegravir to Truvada for HIV prophylaxis confirms superiority. ViiV says treatment data in women may enable an all-gender approval that eluded Gilead with Descovy.
Regulators in high-income countries have a responsibility to help health authorities in low- and medium- income countries develop regulatory frameworks for cell and gene therapy products to ensure these treatments are available to all, asserts the US FDA’s biologics center’s director.
Democratic lawmakers argue the Trump administration’s interpretation of how COVID-19 testing is covered by private insurers runs contrary to the Families First Act and CARES Act. They want the administration to update a FAQ sheet that eliminates certain prerequisites that would qualify patients to be reimbursed for the tests.